Posts tagged “Aurora”
Durham stem cell firm Aldagen sold for up to $40M
Regenerative medicine company Cytomedix has acquired the venture-capital backed company in a $16 million stock deal plus millions more in stock options. Aldagen investors include Intersouth and Aurora Funds.
A purified STEM cell
HyperBranch Medical raises $1M in new funding
The financing for the Durham-based firm that is backed by The Aurora Funds follows a $2.1 million fundraising nearly a year ago. Six existing investors in the company participated in the latest offering,
Metabolon lands $13.1M in fourth round of venture financing
The Triangle-based company, which focuses on biomarker technology, secures a new investor. Local venture firm Aurora Funds also is an investor.
Metabolon’s “Analytical Platform”:
Argos Therapeutics files for $86M initial public offering
The Durham-based biopharmaceutical firm focuses on individualized therapies targeting cancer, HIV and infectious diseases. Its investors include Intersouth Partners and Aurora Funds.
Argos process
Stem cell-focused Aldagen raises $1.1M in funding
The Durham-based company recently withdrew plans for an $80 million stock offering.
A purified STEM cell
Durham-based Regado Biosciences closes on $26M in new financing
The company, which raised $23 million in 2007, has been working on its new round since 2009. Regado is developing a DNA-based system to control bleeding.
Chemical tech firm Centice raises $2.3M in new funding
The Morrisville-based company, which reorganized its management in 2009, says the funds will be used to drive growth of existing, new chemical verification and identification products.
Cetnice's PASS Rx
Roll this: Video tech firm Digitalsmiths raises $12.5M
The Durham-based startup sometimes touted as the "Google of video" is growing face, developing more technology that's finding increasing demand in the online video archiving space.
Clip from "Top Gun" as tagged by Digitalsmiths
Stem cell firm Aldagen withdraws planned $80.5M IPO
The Durham-based life science company cites "market conditions" as the reason for the pullback. It's the second time that the company, which is backed by Triangle venture firms Intersouth and Aurora, has cancelled an IPO.
A purified stem cell
Holden Thorp emphasizes entrepreneurial thinking to Triangle execs
In presentation to Triangle's Association for Corporate Growth chapter, the UNC-CH chancellor and entrepreneur touts the power of universities in sparking creativity and growth. But he also says work remains to be done to help create a more prosperous future.
Venture-backed HyperBranch raises $2M in new funding
The Durham-based medical technology firm secures equity financing from seven investors.
Chapel Hill startup, armed with $15M in funding, advances drug candidate
Cardioxyl Pharmaceuticals, which is backed by Aurora Funds, is developing treatment for heart failure.
NC IDEA accepting applications for fall grant round
Webinar set to help entrepreneurs better understand funding process.
VCs just say 'no' to possible tax changes, but W.H. not listening
In a letter, VCs from the Triangle, southeast and across U.S. call on Senate to deep six a proposal that would change how VCs are taxed. Rep. Barney Frank offers help for VCs plus angels – and IPOs. However, White House has different view.
Metabolon secures two new investors, closes on $6 million in financing
